available for routine immunization in England and Wales the Ministry of Health set up a scheme of poliomyelitis surveillance. The objects were to provide a means of rapid detection pf possible outbreaks of vaccine-induced poliomyelitis, such as occurred in the United States owing to the presence of incompletely inactivated virus in a batch of vaccine (Nathanson and Langmuir, 1963) , and to observe the efficacy of the vaccine. The results were reported by Geffen and Spicer (1960) , Geffen (1960), and Roden (1964) , and though a number of vaccineassociated cases occurred they concluded that the vaccine was both safe and effective.
After live attenuated (Sabin) vaccine was introduced in 1962 the surveillance scheme was reorganized by the Ministry of Health and the Public Health Laboratory Service with the new aim of meeting the theoretical objection that disease might be caused in a very small proportion of persons receiving the vaccine, or their contacts, owing to the virus regaining some of its neurovirulence on passage through the human alimentary tract, a risk which would be detectable only when very large numbers of persons had been immunized. The scheme depended on inquiry into notified cases of poliomyelitis, and also on spec al studies of notified encephalitis and cases in which poliovirus isolation was reported. In assessing the safety of oral vaccine the following circumstances were regarded as significant indicators of possible vaccine-induced disease:
(1 undue frequency of poliomyelitis in recently vaccinated persons ; (2) an aggregation of dates of onset of illness within a month of vaccination, particularly between 5 and 28 days; (3) undue frequency of cases associated with a single batch, or small number of batches of vaccine; and (4) an age, sex, seasonal, and geographical distribution of vaccine-associated cases inconsistent with the distribution of other cases of poliomyelitis. Galbraith (1963) analysed the results for 1962 and concluded there was no evidence of vaccine-induced disease at that time, although studies in the United States (Terry, 1962) suggested that a few cases of paralytic poliomyelitis in vaccinated persons might have been caused by the vaccine and that the risk, though small, was greatest after administration of type 3 monotypic vaccine to adults. These findings have been endorsed by a more recent review of cases in the United States (Special Advisory Committee, 1964 patient's poliomyelitis vaccination history, and details of household members who had received oral vaccine within 28 dayslater extended to 60 days-before onset of the patient's symptoms. Reports were checked weekly against notifications published by the Registrar-General to ensure that a form had been received for every notified case.
A second form was sent for completion by the doctor in clinical charge of the case giving details of the patient's illness, the presence and extent of paralysis, laboratory findings, and the final diagnosis. Subsequently inquiry was made about residual paralysis in vaccine-associated paralytic cases.
Apart from notified cases of poliomyelitis, information was collected from a variety of sources about other cases of neurological disease associated with oral vaccination of the patient or his household contacts. Between April 1963 and April 1964 an inquiry was made into all notified cases of encephalitis and reported deaths from encephalitis to find out whether they were associated with oral poliomyelitis vaccination. In 1963 and 1964 details were obtained of all patients with neurological symptoms from whom poliovirus isolations were reported by public health and hospital laboratories. A few cases of vaccineassociated disease were reported to the laboratory by clinicians.
Results
During 1962-4 428 cases of poliomyelitis were reported to the Epidemiological Research Laboratory (Table I) 
Vaccine-associated Cases of Paralytic Poliomyelitis
There were 20 patients -with paralytic poliomyelitis who had received oral poliomyelitis vaccine within 28 days before onset of symptoms (Table II) , and another 11 whose household contact had been vaccinated within this period (Table III) adults, though a higher proportion of those receiving reinforcing doses of oral vaccine were probably older children and adults. In the United States vaccine-associated cases formed a higher proportion of all cases in adults than in children (Henderson et al., 1964) , but in this study the reverse was true: 13%o of those under the age of 15 years were vaccine-associated compared with 70% of those aged 15 and over. Seasonal and Geographical Distribution.-Since 1962 the former summer peak in incidence of poliomyelitis has almost disappeared and no outbreaks or geographically associated cases of paralytic poliomyelitis have been reported. Galbraith (1963) showed that both the seasonal and geographical distributions of vaccine-associated paralytic cases in 1962 were similar to those of other cases. There was no evidence that the number of vaccine-associated cases was related to the number of doses of vaccine issued in local areas. The few vaccine-associated cases in 1963 to the notice of the Epidemiological Research Laboratory in a variety of ways ; most of them were cases regarded at first as poliomyelitis but in which the diagnosis was later revised.
Cases with Final Diagnoses other than Poliomyelitis
The diagnosis was revised in 106 cases originally reported as poliomyelitis. In nine cases the reason for change of diagnosis was failure to isolate poliovirus, but it was decided to accept the revision only when made on clinical grounds, and these nine were therefore included as paralytic poliomyelitis. The revised diagnoses in 58 of the remaining 97 cases were diseases of the nervous system and in 39 were diseases of other systems.
Eleven (11 %) of the 97 cases were vaccine-associated cases, compared with 31 (11 %) of the 278 cases of confirmed paralytic poliomyelitis. Three of the vaccine-associated cases were diseases of the nervous system, details of which are included in Tables VII and VIII weighed against the benefits of vaccination to the large majority of vaccinees and the community as a whole. The surveillance scheme derived information from several sources, and it is unlikely that many cases of paralytic poliomyelitis occurring in the years under review were not reported in one way or another. Most cases were notified by clinicians to medical officers of health. Only a few additional patients with paralytic poliomyelitis (11 % of the cases in 1963-4) were discovered, most of them by inquiry into reports of the isolation of poliovirus. It is possible that in making a diagnosis of poliomyelitis clinicians were influenced by the patient's vaccination history, but the finding that vaccine-associated cases formed a similar proportion of confirmed cases as of those in which the final diagnosis was not poliomyelitis suggests that vaccineassociated cases were unlikely not to have been reported for this reason.
In judging the safety of oral vaccine it was considered essential to inquire into all types of neurological disease, whether diagnosed as poliomyelitis or not, which could conceivably have been due to the vaccine. Altogether only 38 such cases occurring within 28 days of vaccination of the patient have been recorded, an incidence of about one in every half-million doses given. This may be an underestimate of the true incidence, because cases were collected by systematic inquiries for only part of the time and from a variety of sources, none of which would provide comprehensive records of all cases that might have occurred. Nevertheless, a careful search has not revealed a very large number, and, taking all sources of information together, it seems likely that any substantial incidence of vaccine-associated disease would have been revealed. It is in any case difficult to assess the significance of these cases, for when large numbers of persons are vaccinated some illnesses may be expected by chance alone to be associated chronologically with giving the vaccine. But even if all the incidents recorded were in fact due to the vaccine the frequency of complications compares favourably with, for instance, that following smallpox vaccination (Conybeare, 1964) .
For reasons already given, it can reasonably be assumed that most cases of vaccine-associated paralytic poliomyelitis were notified. There were 20 such cases, an incidence of about one case in every million doses given. But only four cases occurring between 5 and 28 days after vaccination had definite residual paralysis. This represents an incidence of one case in every four and a half million doses given. Three of the four occurred in infants, and, although it is not possible to calculate the incidence by age, most of the vaccine was undoubtedly used for primary immunization of infants.
There was no evidence other than the chronological associations with vaccination to suggest that the vaccine caused disease. (Henderson et al., 1964) , because American practice differed in giving each vaccine virus type separately rather than together as in the United Kingdom. Nevertheless the incidence of vaccine-associated cases with residual paralysis is of the same order as that found in America. The high proportion of vaccine-associated cases among adults in the United States has not been observed, but this may be due to the small number of adults vaccinated in this country. The incidence of vaccine-associated cases was lowest in the U.S. among children aged 5 to 14 years, possibly owing to previous Salk vaccination ; the rate in children under 5 years was nearly as high as in adults.
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The number of cases in each year with a household contact who had received vaccine within 60 days of onset was consistent with the falling incidence of poliomyelitis in these years rather than with the number of doses of oral vaccine given, which suggests it is improbable that vaccine strains are spreading to cause disease among close contacts of vaccinees. It is not possible to be certain that this may not occur after several passages from one contact to another, but on the present evidence this seems unlikely. Service, 1962 ; Gelfand et al., 1963 Galbraith, 1965 We are indebted to the many medical officers of health, hospital clinicians, general practitioners, and virologists who have co-operated in providing information concerning their patients, and to the Ministry of Health for the statistics on the use of oral vaccine.
